If you are looking for stocks that are well positioned to maintain their recent uptrend, Kiniksa Pha

Let's take a look at four stocks, FLXS, ARKO, KNSA and BSET, with impressive net profit margins for

Wells Fargo analyst Eva Fortea Verdejo maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Ove

Kiniksa Pharmaceuticals International, plc (KNSA) could be a great choice for investors looking to m

Does Kiniksa Pharmaceuticals International, plc (KNSA) have what it takes to be a top stock pick for

Kiniksa Pharmaceuticals International, plc (KNSA) was a big mover last session on higher-than-averag

Wedbush analyst David Nierengarten maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Outperf

Let's take a look at four stocks, BTSG, KNSA, ATI and VMI, with stellar net profit margins and risin

KNSA's Arcalyst sales continue to grow as raised 2026 revenue guidance and an expanding IL-1 pipelin

On June 22, 2026, Kiniksa Pharmaceuticals International PLC (KNSA) shares rose 3.5% today, bringing

If you are looking for stocks that are well positioned to maintain their recent uptrend, Kiniksa Pha

TWFG, XPO, MUSA, FLYW and KNSA have been added to the Zacks Rank #1 (Strong Buy) List on June 18, 20

Kiniksa Pharmaceuticals International, plc (KNSA) might move higher on growing optimism about its ea

Kiniksa Pharmaceuticals International, plc (KNSA) Presents at Goldman Sachs 47th Annual Global Healt

On May 29, 2026, Kiniksa Pharmaceuticals International PLC (KNSA) shares fell 4.8% to $48.41, reflec

LONDON, May 29, 2026 (GLOBE NEWSWIRE) -- Kiniksa Pharmaceuticals International, plc (Nasdaq: KNSA) t

Citigroup analyst Geoff Meacham maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Buy and ra

Wedbush analyst David Nierengarten maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Outperf

Kiniksa Pharmaceuticals continues to outperform, with Arcalyst net sales poised to surpass my previo

Wells Fargo analyst Eva Fortea Verdejo maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Ove

Enphase suffers from weaker U.S. demand, Fiverr jumps on Q1 earnings beat, and more

Its Arcalyst has been on the market for years, yet it posted strong sales growth in the period. More

Kiniksa Pharmaceuticals International, plc (KNSA) Q1 2026 Earnings Call Transcript

Jefferies analyst Roger Song maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Buy and raise

U.S. stocks mixed, Nasdaq down 200 points. CommVault shares up 9.9% after beating earnings estimate

Kiniksa Pharmaceuticals International, plc (KNSA) came out with quarterly earnings of $0.27 per shar

Kiniksa Pharmaceuticals (NASDAQ:KNSA) raises FY2026 sales outlook from $900.000 million-$920.000 mil

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly earnings of $0.27 per share which beat the

Oversold stocks in health care sector present buying opportunity. RSI compares stock's strength

Wedbush analyst David Nierengarten maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Outperf

Wells Fargo analyst Eva Fortea Verdejo maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Ove

Wedbush analyst David Nierengarten maintains Kiniksa Pharmaceuticals (NASDAQ:KNSA) with a Outperf

Kiniksa Pharmaceuticals (NASDAQ:KNSA) sees FY2026 sales of $900.000 million-$920.000 million vs $902

Kiniksa Pharmaceuticals (NASDAQ:KNSA) reported quarterly earnings of $0.17 per share which missed th

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

  On Wednesday, 807 companies reached new 52-week lows.